Raffaella Belvedere, Ph.D., works at the Molecular and Cellular Pharmacological Laboratory as a fellowship researcher. She obtained the 5-year Master Level University Degree in “Pharmaceutical Chemistry and Technology” (Top grade cum laude) in 2011. Later, she focused on the research field studying the role of the protein annexin A1 in pancreatic cancer progression, obtaining a doctoral degree with a project entitled “Role of Annexin A1 in tumor progression” at the University of Salerno. She is now focusing on skin wound repair through in vitro and in vivo investigations and is also in collaboration with pharmacological companies. She is co-owner of the patent “Composition for the treatment of skin lesions”. She is a member of the Italian Society of Pharmacology (SIF), and in 2018, she received the prize established by SIF/Farmindustria for the published work “The Pharmaceutical Device Prisma® Skin Promotes in Vitro Angiogenesis through Endothelial to Mesenchymal Transition during Skin Wound Healing”.